Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to version v3.5.5 from v3.5.4, representing a small internal update to the page rather than changes to study details.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision tag was added (v3.5.4) and the previous tag (v3.5.3) was removed, indicating a minor update to the study record in the revision history.SummaryDifference0.1%

- Check47 days agoChange DetectedThis update changes the site’s visible revision/version indicator from v3.5.2 to v3.5.3 without altering the trial’s study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no user-facing content changes indicated.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision updated to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.